Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters
Viruses · 2024
DOI: 10.3390/v16010122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Rana Abdelnabi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, KU Leuven, B-3000 Leuven, Belgiu…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Belgian Federal Government fund for the VirusBank Platform., The Belgian Federal Government, EU4Health programme.
Abstract (Originalsprache)
Since the emergence of the first omicron SARS-CoV-2 variant at the end of 2021, several sub-variants have evolved and become predominant in the human population, showing enhanced transmissibility and ability to (partly) escape the adaptive immune response. The XBB sub-variants (e.g., EG.5.1) have become globally dominant. Besides the XBB sub-variants, a phylogenetically distinct variant, i.e., BA.2.86, is also circulating; it carries several mutations in the spike protein as compared to its parental BA.2 variant. Here, we explored the infectivity of the BA.2.86 and EG.5.1 sub-variants compared to the preceding BA.5 sub-variant in Syrian hamsters. Such preclinical models are important for the evaluation of updated vaccine candidates and novel therapeutic modalities. Following intranasal infection with either variant, throat swabs and lung samples were collected on days 3 and 4 post infection. No significant differences in viral RNA loads in throat swabs were observed between these sub-variants. However, the infectious virus titers in the lungs of EG.5.1- and BA.2.86-infected animals were significantly lower compared to the BA.5-infected ones. The lung pathology scores of animals infected with EG.5.1 and BA.2.86 were also markedly lower than that of BA.5 sub-variant. Together, we show that EG.5.1 and BA.2.86 sub-variants exhibit an attenuated replication in hamsters’ lungs as compared to the BA.5 sub-variant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, KU Leuven, B-3000 Leuven, Belgium.
- Department of Microbiology, Immunology and Transplantation, VirusBank Platform, KU Leuven, B-3001 Leuven, Belgium.
- Statens Serum Institut, DK-2300 Copenhagen, Denmark.
- Department of Microbiology, Immunology and Transplantation, Laboratory of Clinical and Epidemiological Virology, Rega Institute, KU Leuven, B-3000 Leuven, Belgium.
- Department of Imaging and Pathology, Translational Cell and Tissue Research, Division of Translational Cell and Tissue Research, KU Leuven, B-3000 Leuven, Belgium.
ORCID-Profile: Rana Abdelnabi, Ria Lassaunière, Birgit Weynand, Johan Neyts
Förderung
- the Belgian Federal Government fund for the VirusBank Platform.
- The Belgian Federal Government
- EU4Health programme
- European Union
- Innovative Medicines Initiative 2 Joint Undertaking (JU)
- European Union’s Horizon 2020 research and innovation programme
- EFPIA
- BILL & MELINDA GATES FOUNDATION
Zitieren
APA
Abdelnabi, R., Lassaunière, R., Maes, P., Weynand, B., & Neyts, J. (2024). Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters. Viruses. https://doi.org/10.3390/v16010122
Vancouver
Abdelnabi R, Lassaunière R, Maes P, Weynand B, Neyts J. Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters. Viruses. 2024. doi:10.3390/v16010122
BibTeX
@article{Abdelnabi2024,
author = {Abdelnabi, Rana and Lassaunière, Ria and Maes, Piet and Weynand, Birgit and Neyts, Johan},
title = {Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16010122}
}
EUVIMED